Reakiro | Novel Food announcement
As a proactive and leading EU manufacturer of CBD products, Reakiro would like to advise our B2B and White Label clients regarding some changes to our ingestible product range ingredients.
As you will have observed, with the recent announcements concerning Novel Food applications, a significant number of CBD companies have begun generating such applications.
Reakiro is a member of EIHA – European Industrial Hemp Association, representing the interests of Industrial Hemp product producers and whose main goal is to serve and protect the hemp industry in the EU. In regards to Novel Food legislation, Reakiro is in total support of the position conveyed by EIHA consistent and aligned to the following: Hemp leaves and flowers as well as such hemp extracts from industrial hemp, with the natural content of cannabinoids, (i.e. those that are not enriched with isolated CBD) are traditional foods and do not fall under the scope of the Novel Food Regulation.
However, in order to achieve a legal position for their members, EIHA will lead a project dedicated to novel food – EIHA Novel Food Consortium.
Reakiro supports this project alongside other CBD companies.
The very specific group application will be based on different product formulations defined by EIHA, in order to cover all possible CBD products.
A key part of the submission will be that the product formulations submitted under this application will be based on hemp seed oil as a carrier oil.
In order to comply with the said formulations and to meet the conditions of the consortium participation, Reakiro advises that we change MCT oil to hemp seed oil as the carrier in our complete ingestible product range commencing from November 1 2020.
We consider that the benefit of Novel Food compliance and the associated standardization in the industry will benefit all retailers of the REAKIRO brand.
